Characterization of in vitro hemostatic peptide effects by thromboelastography

Area of Science:

• Biochemistry
• Hematology
• Biomaterials

Background:

• Hemostatic agents are crucial for managing bleeding and thrombosis.
• Peptides offer potential as targeted hemostatic agents.
• Thromboelastography (TEG) is a valuable tool for evaluating hemostasis.

Purpose of the Study:

• To validate a thromboelastography (TEG) method for assessing the hemostatic effects of three distinct peptides.
• To characterize the procoagulant and anticoagulant properties of each peptide.
• To elucidate the hemostatic mechanisms of the tested peptides.

Main Methods:

• Utilized thromboelastography (TEG) to analyze the impact of peptides on blood coagulation parameters.
• Tested three peptides: an amphipathic leucine-lysine peptide, melittin, and a fibrinogen γ chain peptide.
• Evaluated dose-dependent effects of each peptide on reaction time (R), coagulation time (K), maximum amplitude (MA), and α angle.

Main Results:

• The amphipathic peptide exhibited biphasic effects: procoagulant at low concentrations and anticoagulant at high concentrations.
• Melittin demonstrated procoagulant effects but reduced clot strength (MA).
• The fibrinogen peptide showed concentration-dependent hemostasis, acting as a procoagulant at optimal doses and anticoagulant at higher doses.

Conclusions:

• The validated TEG method effectively characterized the complex hemostatic profiles of the peptides.
• Peptides can be engineered to modulate hemostasis, offering potential therapeutic applications.
• Findings support the development of peptides for treating hemorrhage or thrombosis.